AWARDDELIVERY ORDEROther than small business
Delivery order 75F40120F80430JOHNSON, MIRMIRAN & THOMPSON, INC.
Overview
Award facts
- Net obligations
- $1.01M
- $1,007,284of $1.01M potential value
- Outlays (paid to date)
- $790.08K
- $790.08K paid of $1.01M obligated$790,078
- Period of performance
- Aug 28, 2020 to Feb 28, 2026
- Ended
- Modifications
- 17
- Latest action Sep 20, 2026
- Contract type
- Delivery order
- PIID 75F40120F80430
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
ENVIRONMENTAL IMPACT ANALYSIS OF THE SUNSCREEN OVER-THE-COUNTER MONOGRAPH
Dates and value
- Award date
- Signed on Aug 28, 2020
- Current value
- $1,007,284Base and exercised options
- Potential value (if all options are exercised)
- $1,007,284
- Parent contract vehicle
- GS00F194CA (FSS, multiple award) — 50 orders recorded under it
Obligations by fiscal year of action
- FY2026: -$450,729 (de-obligation)
- FY2024: $109,237
- FY2023: $15,702
- FY2022: $54,846
- FY2021: $324,912
- FY2020: $953,317
Total across 6 fiscal years: $1,007,284
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 20, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationCOCKEYSVILLE, MD
UEIQGC7CHWHPT51
CAGE code1B2K5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyJOHNSON MIRMIRAN & THOMPSON INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Cockeysville, Baltimore County, Maryland 21030-2059
- Congressional district (place of performance)
- MD-02As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- B537SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- No set-aside used
- Contract pricing
- Labor hoursZ
- Offers received
- 3
Contract details
- Subcontracting plan
- Commercial subcontract planG
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Transaction history
Modification history
- Base award
- Aug 28, 2020Base obligation at award: $953,317
- Latest action
- Sep 20, 2026 — CloseoutModification P00017; obligation change -$450,729; administrative: no change in scope or value
- Latest substantive action
- May 10, 2024 — Supplemental agreement (within scope)Modification P00013; obligation change +$109,237
- Latest funding action
- Aug 2, 2023 — Funding onlyModification P00010; obligation change +$15,702; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action13
- Supplemental agreement (within scope)1
- Funding only1
- Change order1
- Closeout1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$450,729
- Latest action: change in base and all options
- -$2,547,016
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- FSSC
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Federal Acquisition Service4732
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 18
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2020/2020-0600-000
- 075-2021/2021-0600-000
- 075-2022/2022-0600-000
- 075-2023/2023-0600-000
- 075-2024/2024-0600-000
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression